MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
+0.01
(+0.36%)
After-Hours: 20:00
MEI Pharma Cash from Investing (Quarterly): 14.70M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.70M |
| June 30, 2024 | 19.54M |
| March 31, 2024 | 0.122M |
| December 31, 2023 | 24.52M |
| September 30, 2023 | 4.957M |
| June 30, 2023 | 19.40M |
| March 31, 2023 | 10.02M |
| December 31, 2022 | 10.53M |
| September 30, 2022 | 13.74M |
| June 30, 2022 | 20.11M |
| March 31, 2022 | 15.16M |
| December 31, 2021 | -43.37M |
| September 30, 2021 | 14.99M |
| June 30, 2021 | 9.988M |
| March 31, 2021 | 15.39M |
| December 31, 2020 | -5.144M |
| September 30, 2020 | 4.476M |
| June 30, 2020 | -85.05M |
| March 31, 2020 | 9.103M |
| December 31, 2019 | -35.32M |
| September 30, 2019 | 4.967M |
| June 30, 2019 | 9.955M |
| March 31, 2019 | 9.768M |
| December 31, 2018 | -0.193M |
| September 30, 2018 | 4.788M |
| Date | Value |
|---|---|
| June 30, 2018 | -59.43M |
| March 31, 2018 | 5.098M |
| December 31, 2017 | 4.963M |
| September 30, 2017 | 5.042M |
| June 30, 2017 | -0.04M |
| March 31, 2017 | -5.012M |
| December 31, 2016 | 5.008M |
| September 30, 2016 | -10.03M |
| June 30, 2016 | 0.029M |
| March 31, 2016 | 5.002M |
| December 31, 2015 | 0.026M |
| September 30, 2015 | 4.915M |
| June 30, 2015 | 4.999M |
| March 31, 2015 | 4.99M |
| December 31, 2014 | -30.04M |
| September 30, 2014 | 9.995M |
| June 30, 2014 | -0.038M |
| March 31, 2014 | -15.02M |
| December 31, 2013 | -20.00M |
| September 30, 2013 | -0.006M |
| June 30, 2013 | -0.01M |
| March 31, 2013 | -0.024M |
| December 31, 2012 | -0.002M |
| September 30, 2012 | -0.002M |
| June 30, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-85.05M
Minimum
Jun 2020
24.52M
Maximum
Dec 2023
1.893M
Average
10.28M
Median
Cash from Investing (Quarterly) Benchmarks
| Avid Bioservices Inc | -1.311M |
| Evoke Pharma Inc | -- |
| Revance Therapeutics Inc | 23.29M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.45M |
| Free Cash Flow | -43.43M |
| Free Cash Flow Per Share (Quarterly) | -1.718 |
| Free Cash Flow Yield | -234.5% |